Phase
Condition
Hepatic Fibrosis
Treatment
Quantitative ultrasound (DeepUSFF)
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with clinically suspected MASLD based on abnormal ultrasound or liverfunction tests requiring liver ultrasound or MRI examination
BMI ≥25 kg/m² or waist circumference >90 cm (male) or >80 cm (female), suggestinghigh likelihood of fatty liver disease
Living liver transplant donors requiring preoperative liver ultrasound or MRIexamination
Age ≥18 years
Understanding and signing informed consent
Exclusion
Exclusion Criteria:
- Significant alcohol consumption in the past 2 years:
Male: ≥30-60g/day average alcohol intake Female: ≥20-50g/day average alcohol intake
-Chronic liver disease:
Histological diagnosis of chronic liver disease HBsAg positive Anti-HCV positive Other suspected chronic liver diseases
-Liver failure:
Serum albumin <3.2 g/dL INR >1.3 Direct bilirubin >1.3 mg/dL
History of esophageal varices, ascites, hepatic encephalopathy, or acute biliaryobstruction
History of liver cancer diagnosis or treatment
History of liver surgery
Pregnancy
Inability to obtain adequate liver ultrasound imaging:
Patient cooperation impossible Inadequate image acquisition as determined by investigator
-Inability to obtain adequate liver MRI imaging: Patient cooperation impossible Severe obesity preventing MRI examination MRI contraindications (cardiac pacemaker, etc.) Other factors preventing adequate imaging as determined by investigator
Study Design
Study Description
Connect with a study center
Seoul National University Hospital
Seoul 1835848, Seoul 1835847 03080
South KoreaActive - Recruiting
southwoods imaging (Northeastern Ohio Radiology Research and Education Fund )
Boardman 5147784, Ohio 5165418 44512
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.